ADCOCK:  5,881   +27 (+0.46%)  14/11/2018 00:00

South African drugmaker Adcock Ingram FY profit up 26 percent

JOHANNESBURG, Aug 29 (Reuters) - South African drugmaker Adcock Ingram on Tuesday posted a 25.5 percent increase in full-year profit as margins were boosted by higher demand for antiretroviral drugs used to treat HIV.

The drugmaker reported headline earnings per share (HEPS) for the year ended June 30 of 387.7 cents versus 308.9 cents in the same period a year ago.

Headline EPS is the main profit measure in South Africa that strips out certain one-off items. (Reporting by Nomvelo Chalumbira)

2018-08-29 07:25:49

© 2018 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.